See Related Article on p. 451
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The American Journal of the Medical SciencesAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Atherosclerotic plaque vulnerability in the statin era.Eur Heart J. 2017; 38: 1638-1644
- The immune system in atherosclerosis.Nat Immunol. 2011; 12: 204-212
- Pathogenic immunity in systemic lupus erythematosus and atherosclerosis: Common mechanisms and possible targets for intervention.J Intern Med. 2015; 278: 494-506
- Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus.Annu Rev Med. 2013; 64: 249-263
- Systemic lupus erythematosus.N Engl J Med. 2011; 365: 2110-2121
- Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus.Arthritis Rheum. 1999; 42: 51-60
- Association between chronic immune-mediated inflammatory diseases and cardiovascular risk.Heart. 2018; 104: 119-126
- Risk of coronary artery disease in patients with systemic lupus erythematosus: A systematic review and meta-analysis.Am J Med Sci. 2018; 356: 451-463
- Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus.Arthritis Rheum. 2001; 44: 2331-2337
- Inflammation, atherosclerosis, and coronary artery disease.N Engl J Med. 2005; 352: 1685-1695
- Cardiovascular disease in systemic lupus erythematosus is associated with increased levels of biomarkers reflecting receptor-activated apoptosis.Atherosclerosis. 2018; 270: 1-7
Article info
Publication history
Published online: August 31, 2018
Accepted:
August 27,
2018
Received:
July 27,
2018
Footnotes
Funding: Swedish Heart-Lung Foundation (grant 20170520).
Disclosure: The author has no financial or other conflicts of interest to disclose.
Identification
Copyright
© 2018 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Risk of Coronary Artery Disease in Patients With Systemic Lupus Erythematosus: A Systematic Review and Meta-analysisThe American Journal of the Medical SciencesVol. 356Issue 5
- PreviewThe association between chronic inflammation and the accelerated development of atherosclerosis is well recognized. However, it remains controversial as to whether the risk of coronary artery disease (CAD) is elevated in patients with systemic lupus erythematosus (SLE). The objective of this meta-analysis was to obtain a better estimate of the risk of CAD in patients with SLE.
- Full-Text
- Preview
